Literature DB >> 24382012

Cross-sectional serosurvey of avian influenza antibodies presence in domestic ducks of Kathmandu, Nepal.

S Karki1, B Lupiani, C M Budke, S Manandhar, R Ivanek.   

Abstract

Kathmandu, Nepal has been classified as a high-risk area for highly pathogenic avian influenza (HPAI) by the Nepali Government. While ducks have an important role in the transmission of avian influenza viruses (AIV), including HPAI, seroprevalence of antibodies to AIV in domestic ducks of Kathmandu has never been assessed. The objectives of this study were (i) to estimate the prevalence of seroconversion to AIV in domestic ducks in major duck-raising areas of Kathmandu and (ii) to assess the effect of age, sex, presence of swine and the number of ducks on the farm on the carriage of antibodies to AIV in these ducks. From April through July of 2011, a cross-sectional study was conducted and a total of 310 ducks in the major duck-raising areas of Kathmandu were sampled. The estimated prevalence of AIV antibodies was 27.2% [95% confidence interval (CI): 24.6-29.5]. Of 62 enrolled farms, 42% had at least one seropositive duck. Half of the enrolled farms also kept pigs of which 52% had at least one seropositive duck. Bivariate analysis indicated association between ducks' seroconversion to AIV and their age, sex and farm size. However, the final multivariable model, after controlling for clustering of ducks within farms, identified age as the only significant risk factor. Based on this model, ducks older than 1 year of age were more likely to be seropositive compared to ducks <6 months of age [odds ratio = 2.17 (1.07-4.39)]. These results provide baseline information about the AIV seroprevalence in domestic ducks in the major duck-raising areas of Kathmandu and identify a high-risk group that can be targeted in surveillance activities. Future studies should be conducted to differentiate the subtypes of AIV present among domestic ducks in Kathmandu, with particular interest in the presence of HPAI viruses.
© 2014 Blackwell Verlag GmbH.

Entities:  

Keywords:  Avian influenza; antibodies; ducks; risk factors; seroprevalence

Mesh:

Substances:

Year:  2013        PMID: 24382012     DOI: 10.1111/zph.12097

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  6 in total

1.  Surveillance of Influenza A Virus and Its Subtypes in Migratory Wild Birds of Nepal.

Authors:  Dibesh Karmacharya; Sulochana Manandhar; Ajay Sharma; Tarka Bhatta; Pratikshya Adhikari; Adarsh Man Sherchan; Bishwo Shrestha; Manisha Bista; Rajesh Rajbhandari; Mohinder Oberoi; Khadak Bisht; Jean-Marc Hero; Ravi Dissanayake; Maheshwar Dhakal; Jane Hughes; Nitish Debnath
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 2.  Disaster response under One Health in the aftermath of Nepal earthquake, 2015.

Authors:  G V Asokan; A Vanitha
Journal:  J Epidemiol Glob Health       Date:  2016-04-05

3.  One health approach in Nepal: Scope, opportunities and challenges.

Authors:  Krishna Prasad Acharya; Surendra Karki; Kshitiz Shrestha; Krishna Kaphle
Journal:  One Health       Date:  2019-08-12

4.  Risk Factors Associated with Avian Influenza Subtype H9 Outbreaks in Poultry Farms of Central Lowland Nepal.

Authors:  Deepak Subedi; Parshuram Phuyal; Suman Bhandari; Milan Kandel; Shambhu Shah; Gaurav Rawal; Surendra Karki; Santosh Dhakal
Journal:  Infect Dis Rep       Date:  2022-07-18

5.  An epidemiological study of avian influenza A (H5) virus in nomadic ducks and their raising practices in northeastern Bangladesh, 2011-2012.

Authors:  Shamim Sarkar; Salah Uddin Khan; Andrea Mikolon; Mohammad Ziaur Rahman; Jaynal Abedin; Nord Zeidner; Katherine Sturm-Ramirez; Stephen P Luby
Journal:  Influenza Other Respir Viruses       Date:  2017-01-02       Impact factor: 4.380

6.  Risk factors associated with Avian Influenza subtype H9 outbreaks in poultry farms in Kathmandu valley, Nepal.

Authors:  Tulsi Ram Gompo; Bikas Raj Shah; Surendra Karki; Pragya Koirala; Manju Maharjan; Diker Dev Bhatt
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.